---
title: "Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297104505.md"
description: "The outcomes of AIntibody, the inaugural global AI antibody design contest, have been officially released in Nature Biotechnology. Recognized as the industry's most demanding evaluation, all submissions were verified. The event took place in Shanghai and Laguna Hills, California, and the publication was made on August 26, 2026, through PRNewswire."
datetime: "2026-08-27T00:45:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297104505.md)
  - [en](https://longbridge.com/en/news/297104505.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297104505.md)
generator: "portal-rs"
---

# Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result

The outcomes of AIntibody, the inaugural global AI antibody design contest, have been officially released in Nature Biotechnology. Recognized as the industry's most demanding evaluation, all submissions were verified. The event took place in Shanghai and Laguna Hills, California, and the publication was made on August 26, 2026, through PRNewswire.

## Related News & Research

- [Revolut wins conditional US banking license](https://longbridge.com/en/news/297940570.md)
- [Vance: 'We believe fed should lower rates'](https://longbridge.com/en/news/297947325.md)
- [AMD vs. Oracle: One AI Stock Is a Buy, the Other's Future Is Cloudy, Says Top Investor](https://longbridge.com/en/news/297929180.md)
- [Why Dell's Blowout Q2 Gives Investors No Reason to Stay on the Sidelines](https://longbridge.com/en/news/297913696.md)
- [BUZZ-Street View: Broadcom's pipeline soothes AI spending doubts](https://longbridge.com/en/news/297905938.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**